Immunotherapy: TIMING OF DONOR SELECTION ON CD45RA-MEMORY T CELLS AS ADOPTIVE CELL THERAPY FOR COVID-19

por Al-Akioui, K., Díaz-Almirón, M., Vicario, J.L., Balas, A., Hidalgo, M. Moreno, Soria, B., Perez-Martinez, A., Ferreras, C.
Publicado 2022

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.

por Durán, C., Martín Cortázar, C., Ferreras, C., Navarro Zapata, A., Clares Villa, L., Al-akioui, K., Escuredo, A., Pernas, A., Galán, V., Bueno, D., Sisinni, L., Pérez Martínez, A.
Publicado 2022